How GH Secretagogues Work and Their Potential for Anti-Aging | Research

The takeaway

Review of GH secretagogues (including MK-677) as functional somatostatin antagonists that restore youthful GH secretion patterns in aging adults.

Functional somatostatin antagonism
GH secretagogues override somatostatin's inhibitory effects to restore GH pulsatility in aging adults

What the researchers found

GH secretagogues function as somatostatin antagonists at the hypothalamic-pituitary level and can restore youthful GH secretion patterns in elderly subjects.

Why it matters

Age-related GH decline contributes to loss of muscle mass, bone density, and vitality. GH secretagogues offer a way to restore the body's own GH production rather than replacing it with injections, potentially maintaining more natural regulatory controls.

How the study worked

Review article synthesizing mechanistic studies and clinical trial data on GH secretagogues in aging populations.

What this study cannot tell us

Review from 1998 — long-term safety data for GH secretagogues in aging were not yet available. GH restoration doesn't necessarily translate to clinically meaningful anti-aging outcomes. Potential risks of sustained GH elevation in elderly not fully characterized.

How to read the evidence

Review article combining mechanistic and clinical data. Provides strong conceptual framework but relies on relatively short-term clinical studies for aging applications.

When this study was published

Published in 1998, this review captures early clinical enthusiasm for GH secretagogues in aging. Subsequent long-term studies (particularly with MK-677) provided additional safety and efficacy data.

The bigger picture

The concept of restoring endogenous GH secretion rather than replacing it with exogenous GH represents a fundamental shift in anti-aging endocrinology. GH secretagogues maintain the body's feedback systems, potentially offering a safer long-term approach than GH injections for addressing age-related hormonal decline.

Questions still open

Does restoring GH levels in elderly actually improve functional outcomes?
What are the long-term cancer risks of sustained GH secretagogue use in aging?
Is there an optimal age to begin GH secretagogue therapy for maximum benefit?

Common questions

What is somatostatin and why does it increase with age?

Somatostatin is a hormone that inhibits growth hormone release. As we age, somatostatin activity increases, which is a major reason why GH levels decline. GH secretagogues work by overriding this increased somatostatin brake.

Is using a GH secretagogue the same as taking growth hormone?

No. GH secretagogues stimulate your body to produce its own GH in natural pulsatile patterns, while GH injections provide synthetic GH directly. Secretagogues maintain feedback regulation, which may be safer for long-term use.

Read the original research

Growth hormone secretagogues: mechanism of action and use in aging.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 8(1), 13-20

View on PubMed ↗

Citation

Fuh, V L; Bach, M A. (1998). Growth hormone secretagogues: mechanism of action and use in aging.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 8(1), 13-20.